Gruenenthal GmbH

Osteoarthritis Pain

Clinical research includes interventions for moderate to severe pain linked to osteoarthritis of the knee, with attention to symptom control and joint-related pain burden.

  • Knee osteoarthritis
  • Intra-articular pain treatment
  • Musculoskeletal pain

Work in this area reflects a focus on orthopaedic pain management and the clinical evaluation of therapies intended for localized joint discomfort.

Analgesic Development

Research activity also covers broader pain treatment programs, including candidates designed to address persistent or treatment-relevant pain conditions.

  • Analgesia
  • Chronic pain
  • Localized pain therapy

The sponsor’s portfolio shows interest in therapies that target pain relief across different clinical contexts.

Safety and Tolerability

Several studies examine the safety profile and tolerability of investigational pain therapies in human participants.

  • Adverse event monitoring
  • Human volunteer studies
  • Early clinical evaluation

This area includes assessment of how new therapeutic candidates are handled in healthy volunteers and in patients with pain-related conditions.

Pharmacokinetics

Research also includes pharmacokinetic evaluation of new compounds, with interest in how candidate therapies are absorbed, distributed, and processed in the body.

  • Drug disposition
  • Exposure assessment
  • Healthy participant studies

These studies support development in pain medicine by characterising investigational agents intended for clinical use.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Safety of RTX-GRT7039 and Ropivacaine Hydrochloride Injections for Patients with Moderate to Severe Knee Osteoarthritis Pain

    Not recruiting

    1 1 1 1
    Bulgaria Poland Romania